Skip to main content
logo
Basma Adeem Medical company (TADAWUL:9626)
Saudi Arabia flag Saudi Arabia · Delayed Price · Currency is SAR
6.06
0.00 (0.00%)
Sep 1, 2026, 3:10 PM AST

TADAWUL:9626 Financials Overview

Millions SAR. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
54.9345.4633.9226.5221.92
Revenue Growth
20.83%34.02%27.88%20.99%-
Gross Profit
15.8613.3111.028.336.9
Operating Income
9.898.066.965.594.21
Net Income
9.537.36.34.873.78
Earnings Per Share
0.520.400.550.51-
EPS Growth
27.97%-25.77%6.42%--

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
39.2439.3520.058.125.16
Total Debt
20.5914.2811.794.375.12
Net Cash (Debt)
18.6525.078.253.750.04
Net Cash Growth
-25.62%203.72%120.28%9671.36%-
Net Cash Per Share
1.011.390.710.39-

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
12.7711.377.985.217.04
Capital Expenditures
-6.06-6.61-1.32-1.14-1.8
Free Cash Flow
6.714.766.664.075.24
Free Cash Flow Growth
40.94%-28.52%63.68%-22.33%-

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
28.87%29.29%32.50%31.41%31.46%
Operating Margin
18.00%17.72%20.53%21.07%19.20%
Pretax Margin
19.31%18.15%20.00%19.06%17.90%
Profit Margin
17.35%16.07%18.58%18.36%17.26%
FCF Margin
12.22%10.47%19.64%15.34%23.90%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
PE Ratio
12.4514.11---
P/FCF Ratio
17.6921.64---
PS Ratio
2.162.27---